- Record: found
- Abstract: not found
- Article: not found
Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Older Patients with Type 2 Diabetes: a Real-World Evidence Study
Juana Carretero Gómez ,
José Carlos Arévalo Lorido ,
Ricardo Gómez Huelgas ,
Dolores García de Lucas ,
Lourdes Mateos Polo ,
José Manuel Varela Aguilar ,
Jose Miguel Seguí Ripoll ,
Javier Ena
September 2018
September 2018
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Scientific literature about the combination of glucagon-like peptide-1 receptor agonists
(GLP-1ra) and sodium-glucose cotransporter 2 (SGLT2) inhibitors in older patients
is scarce. We sought to assess the real-world efficacy and safety of SGLT2 inhibitors
and GLP-1ra combination therapy in older patients (>65 years of age).